The Background Parenchymal Enhancement in Preoperative Breast MRI: The Effect on Tumor Extent Evaluation

The Background Parenchymal Enhancement in Preoperative Breast MRI: The Effect on Tumor Extent Evaluation

Objective: To evaluate whether the level of background parenchymal enhancement (BPE) on MRI has an effect on the accurate assessment of tumor extent of breast cancer. Methods: This retrospective study included the preoperative MR images from 62 patients, who had been diagnosed with breast cancer an...

Full description

Bibliographic Details
Main Author:	Shanigarn Thiravit
Format:	Article
Language:	English
Published:	Mahidol University 2017-09-01
Series:	Siriraj Medical Journal
Subjects:	Breast MRI background enhancement breast cancer
Online Access:	https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/99634

Similar Items

The Background Parenchymal Enhancement in Preoperative Breast MRI: The Effect on Tumor Extent Evaluation
by: Shanigarn Thiravit, M.D., et al.
Published: (2017-09-01)

Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI
by: Daniele La Forgia, et al.
Published: (2021-04-01)

Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score
by: Michelle Zhang, et al.
Published: (2021-02-01)

Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis
by: Na Hu, et al.
Published: (2021-02-01)

Differentiating Breast Tumors from Background Parenchymal Enhancement at Contrast-Enhanced Mammography: The Role of Radiomics—A Pilot Reader Study
by: Ioana Boca (Bene), et al.
Published: (2021-07-01)

Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study
by: Gordon P. Watt, et al.
Published: (2020-12-01)

MRI background parenchymal enhancement, fibroglandular tissue, and mammographic breast density in patients with invasive lobular breast cancer on adjuvant endocrine hormonal treatment: associations with survival
by: Roberto Lo Gullo, et al.
Published: (2020-08-01)

Fibroglandular Tissue and Background Parenchymal Enhancement on Breast MR Imaging Correlates With Breast Cancer
by: Xiaoxin Hu, et al.
Published: (2021-09-01)

Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis
by: Merav A. Ben-David, et al.
Published: (2020-02-01)

Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival “early on” in neoadjuvant treatment of breast cancer
by: Karen Drukker, et al.
Published: (2018-04-01)

BIRADS 4 breast lesions: comparison of contrast-enhanced spectral mammography and contrast-enhanced MRI
by: Rabab Yasin, et al.
Published: (2019-09-01)

Contrast-enhanced mammography in comparison with dynamic contrast-enhanced MRI: which modality is appropriate for whom?
by: Rasha Kamal, et al.
Published: (2021-08-01)

The value of dynamic contrast-enhanced MRI in the diagnosis and management of triple-negative breast cancer
by: Heba Azzam, et al.
Published: (2020-02-01)

Lipid-weighted intraoperative photoacoustic tomography of breast tumors: Volumetric comparison to preoperative MRI
by: Ivan Kosik, et al.
Published: (2020-06-01)

The value of dynamic contrast-enhanced MRI in differentiating triple-negative breast cancer from other subtypes
by: Heba Azzam, et al.
Published: (2019-12-01)

Dynamic contrast-enhanced MRI parameters of breast cancer tissue and their correlation with cancer cell proliferation and invasion
by: Yi Guo1, et al.
Published: (2017-06-01)

Triple negative breast cancer: MRI features in comparison to other breast cancer subtypes with correlation to prognostic pathologic factors
by: Noha Mohamed Osman, et al.
Published: (2014-12-01)

Comparison of Diagnostic Efficacy Between Contrast-Enhanced Ultrasound and DCE-MRI for Mass- and Non-Mass-Like Enhancement Types in Breast Lesions
by: Liu W, et al.
Published: (2020-12-01)

Breast cancer in dense breasts: comparative diagnostic merits of contrast-enhanced mammography and diffusion-weighted breast MRI
by: Reham Anwar, et al.
Published: (2021-02-01)

Role of diffusion weighted imaging and dynamic contrast enhanced magnetic resonance imaging in breast tumors
by: Magda Ali Hany El Bakry, et al.
Published: (2015-09-01)

The comparison of high-resolution diffusion weighted imaging (DWI) with high-resolution contrast-enhanced MRI in the evaluation of breast cancers
by: Ohno, Ayami
Published: (2020)

A meta‐analysis of contrast‐enhanced spectral mammography versus MRI in the diagnosis of breast cancer
by: Wanqing Xiang, et al.
Published: (2020-06-01)

Role of diffusion weighted images combined with breast MRI in improving the detection and differentiation of breast lesions
by: Waleed Hetta
Published: (2015-03-01)

Can contrast-enhanced mammography replace dynamic contrast-enhanced MRI in the assessment of sonomammographic indeterminate breast lesions?
by: Rasha Mohamed Kamal, et al.
Published: (2020-04-01)

Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study
by: Carrie B. Hruska, et al.
Published: (2019-03-01)

Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study
by: Carrie B. Hruska, et al.
Published: (2018-06-01)

Diagnostic Accuracy of Contrast-Enhanced MRI for Detecting the Malignant Breast Lesions
by: Naila Parveen, et al.
Published: (2021-03-01)

Can DWI-MRI be an alternative to DCE-MRI in the diagnosis of troublesome breast lesions?
by: Lamiaa Mohamed Bassam Hashem, et al.
Published: (2021-05-01)

MRI for breast cancer: Current indications
by: Haydee Ojeda-Fournier, et al.
Published: (2009-04-01)

Unenhanced breast MRI: could it replace dynamic breast MRI in detecting and characterizing breast lesions?
by: Reham Khalil, et al.
Published: (2020-01-01)

Blood Oxygenation Level Dependent Magnetic Resonance Imaging (MRI), Dynamic Contrast Enhanced MRI, and Diffusion Weighted MRI for Benign and Malignant Breast Cancer Discrimination: A Preliminary Experience
by: Roberta Fusco, et al.
Published: (2021-05-01)

Can Breast Magnetic Resonance Imaging Demonstrate Characteristic Findings of Preoperative Ductal Carcinoma In Situ in Taiwanese Women?
by: Ting-Kai Leung, et al.
Published: (2010-07-01)

The additive role of dynamic contrast-enhanced and diffusion-weighted MR imaging in preoperative staging of breast cancer
by: Lamiaa Mohamed Bassam Hashem, et al.
Published: (2021-01-01)

Breast MRI, digital mammography and breast tomosynthesis: comparison of three methods for early detection of breast cancer
by: Dragana Roganovic, et al.
Published: (2015-11-01)

Additive value of texture analysis based on breast MRI for distinguishing between benign and malignant non-mass enhancement in premenopausal women
by: Yu Tan, et al.
Published: (2021-03-01)

Breast imaging screening in a BRCA1-mutated lactating patient: A potential pitfall mimicking malignancy
by: Alice Casinelli, MD, et al.
Published: (2021-10-01)

Role of MRI diffusion as an adjunct to contrast enhanced MRI of the breast for the evaluation of breast cancer patients receiving neoadjuvent chemotherapy
by: Hebatalla El Kassas, et al.
Published: (2016-12-01)

Focal angiomatosis of the breast with MRI and histologic features
by: Yasmin Mekhail, MD, et al.
Published: (2017-06-01)

Characterizing Errors in Pharmacokinetic Parameters from Analyzing Quantitative Abbreviated DCE-MRI Data in Breast Cancer
by: Kalina P. Slavkova, et al.
Published: (2021-06-01)

Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer，a retrospective study
by: Yamaguchi, Ayane
Published: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hcevpqflk228gi0otpr8bgvfgc